1. Firefighting
1.1. Day in life
1.1.1. 2-3hrs
1.1.1.1. Newly admitted
1.1.1.1.1. Medicines reconciliation
1.1.2. 2-3 hrs
1.1.2.1. Surveillance
1.1.2.1.1. Ongoing review
1.1.2.1.2. Monitoring
2. Challenges
2.1. People
2.1.1. WTE
2.1.1.1. 40% resourced
2.1.1.1.1. Australia
2.1.2. Skill mix
2.1.2.1. Assistant grade
2.1.2.1.1. UK standard
2.2. Risk
2.2.1. Safety
2.2.1.1. See people
2.2.1.2. National Cancer Control Program
2.2.1.2.1. Audit
2.2.1.3. Medication Error
2.2.1.3.1. Admission
2.2.1.3.2. During stay
2.2.1.3.3. Discharge
2.2.1.4. Trainees
2.2.1.4.1. Nurses in training
2.2.1.4.2. Drs in training
2.2.2. Financial
2.2.2.1. €500,000/week
2.2.2.1.1. €300,000 Cancer Care
2.2.2.2. Biologicals++
2.3. 5/7 model
2.3.1. 21st century
3. Proactive stuff
3.1. Risk reduction
3.1.1. DOAcs
3.1.1.1. Safety checklist
3.1.1.2. Safety checklist
3.1.1.3. Epidural puncture
3.1.1.4. Bridging guidelines
3.1.2. Intravenous medicines
3.1.3. Antimicrobials
3.1.4. New drugs
3.1.4.1. Ticagrelor
3.1.5. Chemotherapy challenges
3.1.5.1. Massive
4. Training
4.1. Med school
4.1.1. 4 years
4.1.2. Examinable fail
4.1.2.1. 2015
4.1.3. Pharmacist shadowing
4.1.3.1. 2016
4.2. Nursing school
4.3. IV Education
5. Future
5.1. Overseas
5.1.1. 6/7 day model
5.1.2. On-call
5.1.3. Community Formulary Rx
5.1.4. > Pharmacoeconomic debate
5.1.5. > MDT collaboration
5.1.6. Discharge prescribing quality